ArticleBriefings in bioinformatics2026
Gillespie-based simulation and inference for non-Markovian stochastic reaction networks.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Discrete stochastic processes are widespread across physics, chemistry, ecology, and beyond. In computational biology and epidemiology, however, most simulators still assume Markovian kinetics with memoryless dynamics, despite growing evidence for history-dependent effects in gene regulation, RNA transcription, cell differentiation, and infection. This reliance on Markovian models limits the routine use and comparison of more realistic, memory-aware descriptions. Here, we develop and benchmark a unified framework for simulating non-Markovian reaction networks using Gillespie-based algorithms. We implement multiple algorithmic classes, including exact, rejection-based, delay-based, and hybrid Markovian/non-Markovian schemes, and compare them across representative biological models. Across three case studies, we show that non-Markovian waiting times can qualitatively change population-level predictions, and that delay-based approximations can break down when intrinsic system timescales approach the imposed delays. We further show how population-level measurements can be used to infer otherwise inaccessible waiting-time distributions, and how non-Markovian structure can be leveraged for sensitivity analysis and statistical inference. To support broad use of these approaches, we release NoMaSS (Non-Markovian Stochastic Simulations), an open-source Python library that provides a unified interface to a wide range of non-Markovian Gillespie algorithms and enables hybrid Markovian/non-Markovian models (https://github.com/AI-SysBio/NoMaSS).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.